Effect of Recombinant Activated Factor VII (rFVIIa) on Intraoperative Blood Loss during Pediatric Brain Surgery [A Clinical and Thromboelastographic Study]
Heba Omar Ahmed Omar;
Abstract
There is a clinical need for one or more new hemostatic agents to supplement a help in controlling bleeding in pediatric brain tumor, which cannot be controlled by surgical intervention, local hemostatic agents and transfusion of blood products.
Recombin
Recombin
Other data
| Title | Effect of Recombinant Activated Factor VII (rFVIIa) on Intraoperative Blood Loss during Pediatric Brain Surgery [A Clinical and Thromboelastographic Study] | Other Titles | تأثير العامل السابع معاد الإتحاد النشط على فقدان الدم أثناء العملية في جراحة المخ للأطفال | Authors | Heba Omar Ahmed Omar | Keywords | Effect of Recombinant Activated Factor VII (rFVIIa) on Intraoperative Blood Loss during Pediatric Brain Surgery [A Clinical and Thromboelastographic Study] | Issue Date | 2010 | Description | There is a clinical need for one or more new hemostatic agents to supplement a help in controlling bleeding in pediatric brain tumor, which cannot be controlled by surgical intervention, local hemostatic agents and transfusion of blood products. Recombin |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 101086r3771.pdf | 224.11 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.